GSK Sues Over Genentech Antibody Patent
GlaxoSmithKline has filed a suit in federal court challenging the validity of a patent belonging to rival Genentech Inc. as it prepares to release a cancer drug....To view the full article, register now.
Already a subscriber? Click here to view full article